Biomarkers of human immunosenescence: impact of Cytomegalovirus infection

Current Opinion in Immunology

Volumn 21, Issue 4, 2009, Pages 440-445

  Derhovanessian, Evelyna ^a   Larbi, Anis ^a   Pawelec, Graham ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BIOLOGICAL MARKER;

AGING; CD8+ T LYMPHOCYTE; CELL AGGREGATION; CELL AGING; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DRUG RESPONSE; ELDERLY CARE; HEALTH STATUS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOPATHOLOGY; IMMUNOSURVEILLANCE; MORTALITY; NONHUMAN; REVIEW; VACCINATION; VIRUS LOAD; VIRUS REACTIVATION;

EID: 68149148869     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2009.05.012     Document Type: Review

References (49)

1. Hakim F.T., and Gress R.E. Immunosenescence: deficits in adaptive immunity in the elderly. Tissue Antigens 70 (2007) 179-189
2. Aspinall R., Del G.G., Effros R.B., Grubeck-Loebenstein B., and Sambhara S. Challenges for vaccination in the elderly. Immun Ageing 4 (2007) 9
3. Provinciali M: Immunosenescence and cancer vaccines. Cancer Immunol Immunother 2009 [Epub ahead of print].
4. Appay V., Almeida J.R., Sauce D., Autran B., and Papagno L. Accelerated immune senescence and HIV-1 infection. Exp Gerontol 42 (2007) 432-437
5. Ostan R., Bucci L., Capri M., Salvioli S., Scurti M., Pini E., Monti D., and Franceschi C. Immunosenescence and immunogenetics of human longevity. Neuroimmunomodulation 15 (2008) 224-240
6. Dorshkind K., Montecino-Rodriguez E., and Signer R.A. The ageing immune system: is it ever too old to become young again?. Nat Rev Immunol 9 (2009) 57-62
7. Johansen J.S., Pedersen A.N., Schroll M., Jorgensen T., Pedersen B.K., and Bruunsgaard H. High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality. Clin Exp Immunol 151 (2008) 260-266
8. Taub D.D., Ershler W.B., Janowski M., Artz A., Key M.L., McKelvey J., Muller D., Moss B., Ferrucci L., Duffey P.L., and Longo D.L. Immunity from smallpox vaccine persists for decades: a longitudinal study. Am J Med 121 (2008) 1058-1064
9. Pawelec G., Derhovanessian E., Larbi A., Strindhall J., and Wikby A. Cytomegalovirus and human immunosenescence. Rev Med Virol 19 (2009) 47-56
10. Weinberger B., Lazuardi L., Weiskirchner I., Keller M., Neuner C., Fischer K.H., Neuman B., Wurzner R., and Grubeck-Loebenstein B. Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol 68 (2007) 86-90
11. Gibson K.L., Wu Y.C., Barnett Y., Duggan O., Vaughan R., Kondeatis E., Nilsson B.O., Wikby A., Kipling D., and Dunn-Walters D.K. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 8 (2009) 18-25
12. Della-Bella S., Bierti L., Presicce P., Arienti R., Valenti M., Saresella M., Vergani C., and Villa M.L. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol 122 (2007) 220-228
13. Agrawal A., Agrawal S., Tay J., and Gupta S. Biology of dendritic cells in aging. J Clin Immunol 28 (2008) 14-20
14. Colonna-Romano G., Bulati M., Aquino A., Vitello S., Lio D., Candore G., and Caruso C. B cell immunosenescence in the elderly and in centenarians. Rejuvenation Res 11 (2008) 433-439
15. Goronzy J.J., Lee W.W., and Weyand C.M. Aging and T-cell diversity. Exp Gerontol 42 (2007) 400-406. Review of the only kinetic study exploring conservation of the CD4 T cell receptor repertoire in human ageing, showing good maintenance of diversity until the 7th or 8th decade of life, but then sudden catastrophic repertoire contraction.
16. Nikolich-Zugich J. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol 8 (2008) 512-522. Review questioning the role of persistent antigenic stress in driving 'immunosenescence' as opposed to the effects of antigen-independent homeostatic T cell proliferation.
17. Blackburn S.D., Shin H., Haining W.N., Zou T., Workman C.J., Polley A., Betts M.R., Freeman G.J., Vignali D.A., and Wherry E.J. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10 (2009) 29-37
18. Tsaknaridis L., et al. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res 74 (2003) 296-308
19. Sergio G. Exploring the complex relations between inflammation and aging (inflamm-aging): anti-inflamm-aging remodelling of inflamm-aging, from robustness to frailty. Inflamm Res 57 (2008) 558-563
20. Lages C.S., Suffia I., Velilla P.A., Huang B., Warshaw G., Hildeman D.A., Belkaid Y., and Chougnet C. Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol 181 (2008) 1835-1848. First demonstration that a mechanism responsible for increased susceptibility to chronic infectious disease reactivation in old animals can be increased in T regulatory cell activity.
21. Zhao J., Yang X., Auh S.L., Kim K.D., Tang H., and Fu Y.X. Do adaptive immune cells suppress or activate innate immunity?. Trends Immunol 30 (2009) 8-12
22. Strindhall J., Nilsson B.O., Lofgren S., Ernerudh J., Pawelec G., Johansson B., and Wikby A. No immune risk profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp Gerontol 42 (2007) 753-761
23. Wikby A., Mansson I.A., Johansson B., Strindhall J., and Nilsson S.E. The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age. Biogerontology 9 (2008) 299-308. First and so far only evidence that the immune risk profile determined in longitudinal studies of Swedish 85-year-olds may begin to predict excess mortality from age 65 years but not from earlier ages.
24. Ben-Smith A., Gorak-Stolinska P., Floyd S., Weir R.E., Lalor M.K., Mvula H., Crampin A.C., Wallace D., Beverley P.C., Fine P.E., and Dockrell H.M. Differences between naive and memory T cell phenotype in Malawian and UK adolescents: a role for Cytomegalovirus?. BMC Infect Dis 8 (2008) 139
25. Miles D.J., et al. Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J Virol 81 (2007) 5766-5776
26. Goronzy J.J., Fulbright J.W., Crowson C.S., Poland G.A., O'Fallon W.M., and Weyand C.M. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 75 (2001) 12182-12187
27. Trzonkowski P., Mysliwska J., Szmit E., Wieckiewicz J., Lukaszuk K., Brydak L.B., Machala M., and Mysliwski A. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination - an impact of immunosenescence. Vaccine 21 (2003) 3826-3836
28. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., Ewen C., Kane K.P., and Bleackley R.C. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176 (2006) 6333-6339
29. Xie D., and McElhaney J.E. Lower GrB+ CD62Lhigh CD8 TCM effector lymphocyte response to influenza virus in older adults is associated with increased CD28null CD8 T lymphocytes. Mech Ageing Dev 128 (2007) 392-400
30. van D.D., Allore H.G., Mohanty S., Ginter S., Newman F.K., Belshe R.B., Medzhitov R., and Shaw A.C. Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults. J Infect Dis 195 (2007) 1590-1597
31. Benedict C.A., Loewendorf A., Garcia Z., Blazar B.R., and Janssen E.M. Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway. J Immunol 180 (2008) 4836-4847
32. Jenkins C., Garcia W., Godwin M.J., Spencer J.V., Stern J.L., Abendroth A., and Slobedman B. Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection. J Virol 82 (2008) 3736-3750
33. Effros R.B. Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine 25 (2007) 599-604
34. Koch S., Larbi A., Ozcelik D., Solana R., Gouttefangeas C., Attig S., Wikby A., Strindhall J., Franceschi C., and Pawelec G. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann N Y Acad Sci 1114 (2007) 23-35
35. Carrasco J., Godelaine D., Van P.A., Boon T., and van der B.P. CD45RA on human CD8 T cells is sensitive to the time elapsed since the last antigenic stimulation. Blood 108 (2006) 2897-2905
36. Heffner M., and Fearon D.T. Loss of T cell receptor-induced Bmi-1 in the KLRG1(+) senescent CD8(+) T lymphocyte. Proc Natl Acad Sci U S A 104 (2007) 13414-13419. An alternative interpretation of the reason for the accumulation of apparently replicatively senescent CD8+ KLRG1+ T cells: apoptosis resistance coupled with retained cytotoxic effector functions as a mechanism for maintaining immunosurveillance by avoiding clonal deletion caused by persistent antigenic challenge.
37. Hadrup S.R., Strindhall J., Kollgaard T., Seremet T., Johansson B., Pawelec G., Thor S.P., and Wikby A. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 176 (2006) 2645-2653
38. Sylwester A.W., et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202 (2005) 673-685
39. Pourgheysari B., Khan N., Best D., Bruton R., Nayak L., and Moss P.A. The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J Virol 81 (2007) 7759-7765
40. Vescovini R., et al. Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects. J Immunol 179 (2007) 4283-4291
41. Day E.K., Carmichael A.J., ten Berge I., Waller E.C., Sissons J.G., and Wills MR. Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus. J Immunol 179 (2007) 3203-3213
42. Dowd J.B., Aiello A.E., and Alley D.E. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol Infect 137 (2009) 58-65
43. Soroceanu L., Akhavan A., and Cobbs C.S. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature 455 (2008) 391-395
44. Stowe R.P., Kozlova E.V., Yetman D.L., Walling D.M., Goodwin J.S., and Glaser R. Chronic herpesvirus reactivation occurs in aging. Exp Gerontol 42 (2007) 563-570
45. Rafailidis P.I., Mourtzoukou E.G., Varbobitis I.C., and Falagas M.E. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 5 (2008) 47
46. Schwanninger A., Weinberger B., Weiskopf D., Herndler-Brandstetter D., Reitinger S., Gassner C., Schennach H., Parson W., Wurzner R., and Grubeck-Loebenstein B. Age-related appearance of a CMV-specific high-avidity CD8+ T cell clonotype which does not occur in young adults. Immun Ageing 5 (2008) 14. This is the first description of the emergence of a shared CMV-specific T cell receptor CDR3 clonotype present in elderly people, not in young people. This clonotype has higher antigen avidity and may be part of an age-associated compensatory mechanism for maintaining effective CMV immunosurveillance in the elderly.
47. Vezys V., Yates A., Casey K.A., Lanier G., Ahmed R., Antia R., and Masopust D. Memory CD8 T-cell compartment grows in size with immunological experience. Nature 457 (2009) 196-199. Unexpected demonstration in mice that the absolute size of the CD8 memory pool is malleable and can double to accommodate new memory cells without the loss of old ones or naïve cells. These data may confound interpretations based on percentages of subsets within the CD8 population and suggest that the 'immunological space' is more flexible than appreciated.
48. Chidrawar S., Khan N., Wei W., McLarnon A., Smith N., Nayak L., and Moss P. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin Exp Immunol 155 (2009) 423-432. Age-associated changes assessed for T cell subsets, B cells, NK cells, and other biomarkers of human immune ageing are all profoundly affected by (caused by?) CMV infection status and not by chronological age per se.
49. Trofe J., Pote L., Wade E., Blumberg E., and Bloom R.D. Maribavir: a novel antiviral agent with activity against cytomegalovirus. Ann Pharmacother 42 (2008) 1447-1457